Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Benztropine mesylate is a prescription anticholinergic medicine used as an adjunct in all forms of parkinsonism and for selected extrapyramidal disorders caused by neuroleptic medicines. It is not recommended for tardive dyskinesia. Oral tablets come in 0.5 mg, 1 mg, and 2 mg strengths. Dosing starts low and rises gradually according to response and adverse reactions.
read more about benztropine ...Benztropine has anticholinergic and antihistaminic activity, though only its anticholinergic action is established as therapeutically significant in parkinsonism. By reducing muscarinic cholinergic activity, the medicine can lessen selected movement symptoms. Its atropine-like actions also account for dry mouth, blurred vision, constipation, reduced sweating, and urinary retention.
Benztropine tablets are used as adjunctive therapy in all forms of parkinsonism. They are also used for extrapyramidal disorders caused by neuroleptic medicines such as phenothiazines. Benztropine is not recommended for tardive dyskinesia since antiparkinsonian anticholinergic medicines do not relieve it and can aggravate its symptoms.
Treatment starts with a low dose and increases by 0.5 mg at five- or six-day intervals to the smallest dose that controls symptoms, up to 6 mg daily. Idiopathic parkinsonism commonly uses 0.5 mg to 6 mg daily. Drug-induced extrapyramidal disorders commonly use 1 mg to 4 mg once or twice daily.
Benztropine can cause dry mouth, constipation, blurred vision, urinary retention, confusion, hallucinations, faster heart rate, reduced sweating, hyperthermia, and heat stroke. Paralytic ileus and toxic psychosis have also occurred. The medicine can impair driving or hazardous work and is contraindicated in children younger than 3 years.
Yes. Its anticholinergic activity is the action established as therapeutically significant in parkinsonism.
No. Benztropine is not recommended for tardive dyskinesia and can aggravate its symptoms.
Current tablet labeling describes gradual increases up to a maximum of 6 mg daily.
Yes. Reduced sweating can lead to hyperthermia or heat stroke, especially during hot weather or with other anticholinergic medicines.
Benztropine. MedlinePlus. https://medlineplus.gov/druginfo/meds/a682155.html. Date Accessed September 16, 2026.
Benztropine. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/benzatropine. Date Accessed September 16, 2026.
Benztropine. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK560633/. Date Accessed September 16, 2026.
DailyMed - BENZTROPINE MESYLATE tablet. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c19664aa-a797-4192-b5f3-e906a7cac048. Date Accessed September 16, 2026.
DailyMed - BENZTROPINE MESYLATE tablet. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e653f9bc-40db-4048-bcf2-6fa46db85895. Date Accessed September 16, 2026.